Pachymeter is a medical device used to measure corneal thickness.
Corneal Pachymetry Market: Introduction
Pachymeter is a medical device used to measure corneal thickness. It is also used to determine endothelial pump and corneal barrier functions. Moreover, a pachymeter helps in determining intraocular pressure in case of glaucoma. Corneal thickness greater than 640 µm increases the risk of corneal decompensation.
Read Report Overview - https://www.transparencymarketresearch.com/corneal-pachymetry-market.html
Ultrasound and optical pachymeters are the two types of device used to perform pachymetry. Ultrasound pachymetry helps in locating endothelial and epithelial layers using high frequency sound waves. Fuch’s dystrophy is a medical condition characterized by rise in corneal fluid, which in turn increases corneal thickness. Wearing contact lenses can cause corneal swelling.
Key Drivers, Restrains, and Opportunities of Global Corneal Pachymetry Market
Rise in prevalence of glaucoma and eye-related disorders is projected to drive the global corneal pachymetry market. Additionally, increase in awareness about eye care is anticipated to propel the global market during the forecast period.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=62313
Rise in prevalence of diabetic retinopathy is another factor expected to augment the global corneal pachymetry market. According to the Centers for Diseases Control and Prevention, glaucoma is the second leading cause of blindness across the world. The World Glaucoma Association estimated that 79.6 million people will have glaucoma in 2020 and the number is projected to reach 111.8 million in 2040.
However, inadequate reimbursement coverage for pachymetry and stringent government regulations are likely to restrain the global corneal pachymetry market
North America to Capture Major Share of Global Corneal Pachymetry Market
North America is projected to account for major share of the global corneal pachymetry market due to well-established health care infrastructure and presence of key players in the region. Moreover, high prevalence of glaucoma in the U.S. is anticipated to propel the market in the region. According to the Centers for Diseases Control and Prevention, about 3 million people in the U.S. had glaucoma in 2019.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=62313
The corneal pachymetry market in Asia Pacific is expected to grow at a rapid pace during the forecast period due to increase in cases of glaucoma and eye-related disorders. According to the International Agency for the Prevention of Blindness, an estimated 17 million individuals had glaucoma in Asia in 2013 and the number is likely to reach 33 million by 2040.
Key Players Operating in Global Corneal Pachymetry Market
The global corneal pachymetry market is highly consolidated due to the presence of small number of key players. These companies hold a major share in their respective regions. Growth strategies adopted by leading players are likely to drive the global corneal pachymetry market.
Pre Book Corneal Pachymetry Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=62313<ype=S
Major players operating in the global corneal pachymetry market are:
- MicroMedical Devices, Inc. (MMD)
- NIDEK CO., LTD.
- OCULUS
- Quantel Medical
- Optovue Incorporated
- DGH Technology, Inc.
- Tomey Corporation
- Sonomed Escalon
- OphthalmologyWeb
- Other prominent players
Browse more Reports by Transparency Market Research:
Biological Safety Testing Market: The rising usage of biological safety testing in various end use industry verticals such as biotechnology as well as pharmaceutical industries, is anticipated to cater several new opportunities for the global biological safety testing market.
Non-Small Cell Lung Cancer Therapeutics Market: Growing approvals for new drugs and non-small cell lung cancer therapeutics by the US FDA (Food and Drug Administration) and other authoritative bodies. Moreover, several other authoritative bodies are now funding several research and development activities and are thus lending their support for the development of the global non-small cell lung cancer therapeutics market.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/